GEHC Ebitda from 2010 to 2024

GEHC Stock   81.43  1.63  2.04%   
GE HealthCare's EBITDA is increasing over the years with very volatile fluctuation. Overall, EBITDA is expected to go to about 2.5 B this year. During the period from 2010 to 2024 GE HealthCare EBITDA annual values regression line had geometric mean of  2,883,496,631 and mean square error of 92371.9 T. View All Fundamentals
 
EBITDA  
First Reported
2010-12-31
Previous Quarter
2.4 B
Current Value
2.5 B
Quarterly Volatility
293.8 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check GE HealthCare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GEHC main balance sheet or income statement drivers, such as Tax Provision of 653 M, Interest Income of 29 M or Discontinued Operations of 15.4 M, as well as many exotic indicators such as Price To Sales Ratio of 1.29, Dividend Yield of 9.0E-4 or PTB Ratio of 5.18. GEHC financial statements analysis is a perfect complement when working with GE HealthCare Valuation or Volatility modules.
  
This module can also supplement various GE HealthCare Technical models . Check out the analysis of GE HealthCare Correlation against competitors.

Latest GE HealthCare's Ebitda Growth Pattern

Below is the plot of the Ebitda of GE HealthCare Technologies over the last few years. It is GE HealthCare's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in GE HealthCare's overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Very volatile
   Ebitda   
       Timeline  

GEHC Ebitda Regression Statistics

Arithmetic Mean2,896,904,000
Geometric Mean2,883,496,631
Coefficient Of Variation10.14
Mean Deviation196,971,733
Median2,838,000,000
Standard Deviation293,775,903
Sample Variance86304.3T
Range1.1B
R-Value0.08
Mean Square Error92371.9T
R-Squared0.01
Significance0.78
Slope5,149,714
Total Sum of Squares1208259.9T

GEHC Ebitda History

20242.5 B
20232.4 B
20223.2 B
20213.5 B
20203.4 B

About GE HealthCare Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include GE HealthCare income statement, its balance sheet, and the statement of cash flows. GE HealthCare investors use historical funamental indicators, such as GE HealthCare's Ebitda, to determine how well the company is positioned to perform in the future. Although GE HealthCare investors may use each financial statement separately, they are all related. The changes in GE HealthCare's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on GE HealthCare's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on GE HealthCare Financial Statements. Understanding these patterns can help to make the right decision on long term investment in GE HealthCare. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EBITDA2.4 B2.5 B

GE HealthCare Investors Sentiment

The influence of GE HealthCare's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in GEHC. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to GE HealthCare's public news can be used to forecast risks associated with an investment in GEHC. The trend in average sentiment can be used to explain how an investor holding GEHC can time the market purely based on public headlines and social activities around GE HealthCare Technologies. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
GE HealthCare's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for GE HealthCare's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average GE HealthCare's news discussions. The higher the estimated score, the more favorable is the investor's outlook on GE HealthCare.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards GE HealthCare in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, GE HealthCare's short interest history, or implied volatility extrapolated from GE HealthCare options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether GE HealthCare Techno offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of GE HealthCare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ge Healthcare Technologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ge Healthcare Technologies Stock:
Check out the analysis of GE HealthCare Correlation against competitors.
Note that the GE HealthCare Techno information on this page should be used as a complementary analysis to other GE HealthCare's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Complementary Tools for GEHC Stock analysis

When running GE HealthCare's price analysis, check to measure GE HealthCare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GE HealthCare is operating at the current time. Most of GE HealthCare's value examination focuses on studying past and present price action to predict the probability of GE HealthCare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GE HealthCare's price. Additionally, you may evaluate how the addition of GE HealthCare to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Stocks Directory
Find actively traded stocks across global markets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Is GE HealthCare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GE HealthCare. If investors know GEHC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GE HealthCare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.976
Dividend Share
0.12
Earnings Share
3.44
Revenue Per Share
42.799
Quarterly Revenue Growth
(0.01)
The market value of GE HealthCare Techno is measured differently than its book value, which is the value of GEHC that is recorded on the company's balance sheet. Investors also form their own opinion of GE HealthCare's value that differs from its market value or its book value, called intrinsic value, which is GE HealthCare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GE HealthCare's market value can be influenced by many factors that don't directly affect GE HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GE HealthCare's value and its price as these two are different measures arrived at by different means. Investors typically determine if GE HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GE HealthCare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.